Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.

Clinics in dermatology - 1 Jan 2000

Tartar Danielle M, Chung Lorinda, Fiorentino David F

Abstract excerpt

Autoimmune connective tissue diseases, including dermatomyositis and systemic sclerosis, have a heterogeneous clinical presentation and prognosis; moreover, their clinical features are often incomplete and overlap with other rheumatic disorders, which can make diagnosis and prognostic stratification challenging. Specific autoantibodies have been associated with certain clinical findings as well as prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antinuclear
Share to Antibodies, Antiphospholipid
Share to Dermatomyositis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exoribonucleases

Share to Exosome Multienzyme Ribonuclease Complex

Share to Interferon-Induced Helicase, IFIH1

Share to Ribonucleoproteins, Small Nucleolar

Share to Ubiquitin-Activating Enzymes

Source

Identifiers

PMID: 30047434
DOI: 10.1016/j.clindermatol.2018.04.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.PMID 30047434Read ↗

Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.Semantic proximity Read ↗

Dermatomyositis and polymyositisSemantic proximity Read ↗

The Significance of Autoantibodies in Juvenile Dermatomyositis.Semantic proximity Read ↗

An update on autoantibodies in scleroderma.Semantic proximity Read ↗

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodiesSemantic proximity Read ↗

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosisSemantic proximity Read ↗

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.Semantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders.Semantic proximity Read ↗

Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response.Semantic proximity Read ↗

Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort.Semantic proximity Read ↗

Myositis-specific autoantibodies and their clinical associations in Idiopathic Inflammatory MyopathiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.